Nature's Sunshine Products, Inc.

How big is Nature's Sunshine Products, Inc.?

As of Jun 18, Nature's Sunshine Products, Inc. has a market capitalization of 274.73 million, with net sales of 456.61 million and a net profit of 10.29 million over the last four quarters. Shareholder's funds are 155.31 million, and total assets amount to 240.85 million.

As of Jun 18, Nature's Sunshine Products, Inc. has a market capitalization of 274.73 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 456.61 million for the latest four quarters, with a net profit of 10.29 million during the same period.<BR><BR>As of Dec 24, the balance sheet shows shareholder's funds of 155.31 million and total assets amounting to 240.85 million.

What does Nature's Sunshine Products, Inc. do?

Nature's Sunshine Products, Inc. is a micro-cap company that manufactures and sells natural health and wellness products, with recent net sales of $113 million and a net profit of $5 million. Key financial metrics include a P/E ratio of 26.00 and a market cap of $274.73 million.

Overview: <BR>Nature's Sunshine Products, Inc. is a natural health and wellness company engaged in the manufacturing and direct selling of nutritional and personal care products, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 113 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 5 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 274.73 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 26.00 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.51 <BR>Return on Equity: 6.38% <BR>Price to Book: 1.70<BR><BR>Contact Details: <BR>Address: 2901 W Blue Grass Blvd Ste 100, LEHI UT: 84043-4189 <BR>Tel: 1 801 3417900 <BR>Website: https://www.naturessunshine.com/us/

Should I buy, sell or hold Nature's Sunshine Products, Inc.?

Who are in the management team of Nature's Sunshine Products, Inc.?

As of March 2022, the management team of Nature's Sunshine Products, Inc. includes J. Christopher Teets (Independent Chairman), Terrence Moorehead (CEO), and several independent directors: Robert Mercer, Richard Moss, Mary Springer, Robert Straus, and Heidi Wissmiller. The team features a blend of executive leadership and independent oversight.

As of March 2022, the management team of Nature's Sunshine Products, Inc. includes the following individuals:<BR><BR>- Mr. J. Christopher Teets, Independent Chairman of the Board<BR>- Mr. Terrence Moorehead, President, Chief Executive Officer, Director<BR>- Mr. Robert Mercer, Independent Director<BR>- Mr. Richard Moss, Independent Director<BR>- Ms. Mary Springer, Independent Director<BR>- Mr. Robert Straus, Independent Director<BR>- Ms. Heidi Wissmiller, Independent Director<BR><BR>This team comprises a mix of executive leadership and independent directors.

Is Nature's Sunshine Products, Inc. technically bullish or bearish?

As of September 3, 2025, Nature's Sunshine Products, Inc. shows a bullish technical trend supported by positive MACD and moving averages, despite a bearish monthly RSI, with a year-to-date return of 14.26%, outperforming the S&P 500.

As of 3 September 2025, the technical trend for Nature's Sunshine Products, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, supporting the positive trend, while the monthly MACD is also bullish, indicating strength over a longer time frame. The daily moving averages are bullish, further reinforcing the bullish stance. However, the monthly RSI is bearish, which presents a divergence in momentum signals. The Bollinger Bands and Dow Theory are both mildly bullish on a weekly and monthly basis, suggesting some upward pressure. <BR><BR>In terms of performance, the stock has returned 14.26% year-to-date and 23.71% over the past year, outperforming the S&P 500, which has returned 12.22% and 17.14% in the same periods, respectively. Overall, the current technical stance is bullish, with moderate strength driven by the MACD and moving averages.

Is Nature's Sunshine Products, Inc. overvalued or undervalued?

As of October 17, 2025, Nature's Sunshine Products, Inc. is considered overvalued with a P/E ratio of 26 compared to the peer average of 21.11, and its 6.30% return over the past year is significantly lower than the S&P 500's 14.08% return, leading to a valuation grade downgrade from attractive to fair.

As of 17 October 2025, the valuation grade for Nature's Sunshine Products, Inc. has moved from attractive to fair. The company is currently overvalued based on its valuation metrics. The P/E ratio stands at 26, which is significantly higher than the peer average of 21.11 for companies like Chromadex Corp. and USANA Health Sciences, Inc., which have P/E ratios of 39.82 and 16.23, respectively. Additionally, the EV to EBITDA ratio of 5.08 is also elevated compared to the peer average of 6.47.<BR><BR>Nature's Sunshine Products, Inc. has shown a return of 6.30% over the past year, which is notably lower than the S&P 500's return of 14.08% during the same period, reinforcing the notion that the stock is overvalued in the current market context.